Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B

article

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3350/CMH.2018.0040
P932PMC publication ID6435969
P698PubMed publication ID30360031

P2093author name stringKwang-Il Kim
Mi Na Kim
Kyu Sung Rim
Seong Gyu Hwang
Hana Park
Soo-Hwan Kim
Joo Ho Lee
Young Eun Chon
Yeonjung Ha
Yun Bin Lee
P2860cites workHistopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.Q51353878
The natural history of chronic hepatitis B virus infectionQ64133519
Hepatitis B virus infectionQ88131866
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manQ26776977
Management of hepatocellular carcinoma: An updateQ27860530
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaQ28394414
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesQ29614505
Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseQ29614930
Management of hepatocellular carcinomaQ29616230
Histological grading and staging of chronic hepatitisQ29619625
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.Q30392056
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.Q30984322
Liver biopsyQ33932981
The clinicopathologic spectrum and management of nonalcoholic fatty liver diseaseQ34470464
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitisQ34617479
AGA technical review on nonalcoholic fatty liver diseaseQ34982453
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; InternatQ35006662
Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatmentQ36467970
KASL clinical practice guidelines: management of nonalcoholic fatty liver diseaseQ37488800
The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Q38676257
Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.Q38677390
Hepatitis B virus. The major etiology of hepatocellular carcinomaQ39199064
Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factorsQ42218044
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseQ44227516
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.Q46573520
Practice guidelines for management of hepatocellular carcinoma 2009Q50247644
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
steatosisQ1365091
chronic hepatitis BQ55779876
P304page(s)52-64
P577publication date2018-10-23
P1433published inClinical and molecular hepatologyQ26853927
P1476titleAssociation between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
P478volume25

Reverse relations

Q92841191Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesiscites workP2860

Search more.